文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒肝肾功能剂量调整

机器学习模型预测他克莫司治疗肾毒性

Development of a predictive model for nephrotoxicity during tacrolimus treatment using machine learning methods.
PubMed 文献 · Br J Clin Pharmacol · 2023-11-28

该研究基于163例口服他克莫司患者的临床数据,构建13种机器学习模型预测60天内血清肌酐升高,表现最佳的SVM模型F2分数为0.750,优于仅依据他克莫司全血浓度的传统模型(0.500)。

要点

  • SVM模型可个体化预测他克莫司相关肾毒性风险
  • 模型表现F2分数0.750,优于传统浓度模型0.500
  • 可在治疗前识别需个体化目标浓度的肾毒性高风险患者

核心结论

  • 利用他克莫司全血浓度及其他患者数据开发的机器学习模型可预测治疗期间肾毒性,并可能辅助识别需个体化目标浓度的肾毒性高风险患者。

研究设计与样本

  • 研究收集163例口服他克莫司患者的医疗记录数据,包括起始时实验室检查、合并用药和他克莫司全血浓度。
  • 基于逻辑回归、支持向量机、梯度提升树、随机森林和神经网络等算法构建13个预测模型。
  • 采用41例患者评估表现最佳模型,并与仅根据他克莫司浓度分类的传统模型比较。

主要发现

  • 表现最佳模型采用支持向量机,F2分数达0.750。
  • 传统模型F2分数为0.500,支持向量机模型表现优于传统模型。

关键数值与推荐

  • 肾毒性定义为他克莫司起始后60天内血清肌酐水平升高。
  • 多数患者诊断为炎症性或自身免疫性疾病。

临床怎么用

  • 该模型可能辅助在治疗前识别需要个体化目标他克莫司浓度的肾毒性高风险患者,以预防肾毒性。

局限性

  • 模型构建与评估样本量较小(分别为163例和41例),需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: When administering tacrolimus, therapeutic drug monitoring is recommended because nephrotoxicity, an adverse event, occurs at supra-therapeutic whole-blood concentrations of tacrolimus. However, some patients exhibit nephrotoxicity even at the recommended concentrations, therefore establishing a therapeutic range of tacrolimus concentration for the individual patient is necessary to avoid nephrotoxicity. This study aimed to develop a model for individualized prediction of nephrotoxicity in patients administered tacrolimus. METHODS: We collected data, such as laboratory test data at tacrolimus initiation, concomitant drugs and tacrolimus whole-blood concentration, from medical records of patients who received oral tacrolimus. Nephrotoxicity was defined as an increase in serum creatinine levels within 60 days of tacrolimus initiation. We built 13 prediction models based on different machine learning algorithms: logistic regression, support vector machine, gradient-boosting trees, random forest and neural networks. The best performing model was compared with the conventional model, which classifies patients according to the tacrolimus concentration alone. RESULTS: Data from 163 and 41 patients were used to construct models and evaluate the best performing one, respectively. Most of the patients were diagnosed with inflammatory or autoimmune diseases. The best performing model was built using a support vector machine; it showed a high F2 score of 0.750 and outperformed the conventional model (0.500). CONCLUSIONS: A machine learning model to predict nephrotoxicity in patients during tacrolimus treatment was developed using tacrolimus whole-blood concentration and other patient data. This model could potentially assist in identifying high-risk patients who require individualized target therapeutic concentrations of tacrolimus prior to treatment initiation to prevent nephrotoxicity.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Noda T, Mizuno S, Mogushi K, et al. Development of a predictive model for nephrotoxicity during tacrolimus treatment using machine learning methods. Br J Clin Pharmacol. 2023. PMID: 37921554. doi:10.1111/bcp.15953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。